Can Paternity Test Be Done During Pregnancy? | The Facts

Yes, prenatal paternity testing is available during pregnancy starting around week 8 with a non-invasive blood draw or later through CVS.

You probably assumed paternity testing meant a cheek swab after delivery — a legal conversation, not a medical one. But the question can come up months before the baby arrives, and the options for answering it have expanded significantly.

The short answer is yes — a paternity test during pregnancy is possible. But the how matters as much as the when. Three distinct methods exist, and they differ in timing, accuracy, safety profile, and cost. Which one fits your situation depends on how early you are in the pregnancy and whether you want zero risk or definitive results.

How Prenatal Paternity Testing Works

All prenatal paternity tests compare fetal DNA with a DNA sample from the alleged father. The difference between methods comes down to where the fetal DNA comes from and how it’s collected.

In non-invasive testing, a simple blood draw from the mother’s arm captures cell-free fetal DNA that circulates naturally in her bloodstream. The lab isolates this DNA and compares it to a cheek swab from the alleged father.

With invasive methods — chorionic villus sampling (CVS) or amniocentesis — the doctor collects fetal cells directly from the placenta or amniotic fluid. These procedures were developed for genetic screening but can also serve paternity testing.

Why The Timing Question Comes Up

The availability of prenatal paternity testing often surprises people who assume they must wait until birth. The appeal is clear: knowing before delivery can inform legal, emotional, and practical decisions. But timing also matters because the options change as pregnancy progresses.

• Week 7–8 option: Non-invasive prenatal paternity (NIPP) testing becomes available. Some commercial labs offer testing at 7 weeks, while Cleveland Clinic notes 8 weeks as the standard start point. No risk to the pregnancy.
• Week 10–13 window: CVS becomes an option. This invasive procedure carries a small miscarriage risk and is less commonly used solely for paternity testing.
• Week 15–20 window: Amniocentesis becomes available. It carries a small miscarriage risk and is typically performed for medical reasons but can provide paternity information as well.
• Postpartum option: A standard cheek swab after birth remains the simplest, lowest-cost, and zero-risk option. The trade-off is waiting.

Early timing appeals to those wanting certainty sooner. Non-invasive testing at 7–8 weeks offers a safety profile that invasive methods cannot match.

What A Non-Invasive Test Involves

A non-invasive prenatal paternity test requires only a blood draw from the mother and a DNA sample — typically a cheek swab — from the alleged father. The lab analyzes the cell-free fetal DNA, which contains the genetic material needed for comparison.

This is the same technology behind NIPT (non-invasive prenatal testing) used to screen for chromosomal conditions. Cleveland Clinic’s overview of the prenatal DNA paternity test notes the method carries no risk to the pregnancy since it only requires a maternal blood draw.

Accuracy is reported to be very high — some testing labs claim 99.9% — though this figure comes from commercial sources rather than peer-reviewed studies. Most medical institutions describe the method as highly reliable when performed after the recommended gestational age.

The non-invasive approach stands apart because it carries no physical risk to the pregnancy. The trade-off is that, unlike CVS or amniocentesis, it is designed specifically for paternity testing and may not be covered by insurance.

Factors That Affect Your Choice

Choosing between prenatal paternity testing methods comes down to balancing three variables: timing, risk, and cost. Each method has a different profile on all three.

1. How early you need results: If you need an answer before the end of the first trimester, NIPP at 7–8 weeks is the only option. CVS can provide results by week 10 but later than NIPP.
2. Your tolerance for procedural risk: NIPP carries zero risk to the pregnancy. CVS has a miscarriage risk of roughly 0.5% to 1.0%. Amniocentesis carries a risk of about 0.25% to 0.5% when performed after 15 weeks.
3. Whether you have a medical reason for invasive testing: CVS and amniocentesis are performed for genetic screening, not just paternity. If you have a medical indication for either, the paternity component comes as an additional benefit.
4. Insurance and cost coverage: NIPP tests are typically not covered by insurance and can cost several hundred dollars or more. CVS and amniocentesis are more likely to be covered if performed for medical indications.

Some testing labs may not perform NIPP for twin or multiple pregnancies. If you’re carrying multiples, check with the specific lab about their policy before ordering a test.

How Invasive Testing Compares On Risk

The miscarriage risk associated with CVS and amniocentesis is well-documented but remains low. Per the CDC’s procedure-related risk data, the CVS miscarriage risk is estimated at 0.5% to 1.0% — roughly 1 in 200 to 1 in 100 procedures. Amniocentesis performed between 15 and 18 weeks carries a risk of approximately 0.25% to 0.5%, or about 1 in 400 to 1 in 200.

These numbers matter in context. The baseline risk of miscarriage in any pregnancy varies by maternal age and gestational age, so the added risk from these procedures is small but real. Amniocentesis before 15 weeks carries a significantly higher miscarriage rate and is not recommended.

For women without a medical indication for invasive testing, the non-invasive option offers a clear advantage. For those who already need CVS or amniocentesis for genetic screening, the paternity test component adds no additional risk — it simply uses the same sample.

The Bottom Line

Yes, a paternity test can be done during pregnancy. Non-invasive testing from around 8 weeks offers a risk-free option with high reported accuracy, while CVS and amniocentesis provide diagnostic-level results but carry a small procedural risk. Your choice depends on how early you need answers and whether you have other medical reasons for invasive testing.

Your obstetrician or midwife can help you weigh the timing, cost, and risk trade-offs specific to your pregnancy and recommend a lab or specialist if you decide to move forward with prenatal testing.